Edition:
India

Mediclinic International PLC (MDCM.L)

MDCM.L on London Stock Exchange

660.60GBp
4:39pm IST
Change (% chg)

-2.20 (-0.33%)
Prev Close
662.80
Open
666.80
Day's High
672.20
Day's Low
659.00
Volume
633,267
Avg. Vol
1,562,263
52-wk High
890.18
52-wk Low
495.40

Latest Key Developments (Source: Significant Developments)

Mediclinic Says Carel Aron van der Merwe To Start As CEO On June 1
Thursday, 29 Mar 2018 

March 29 (Reuters) - Mediclinic International Plc ::MEDICLINIC INTERNATIONAL PLC - RONNIE VAN DER MERWE (CHIEF CLINICAL OFFICER AND CHIEF EXECUTIVE OFFICER) WILL SUCCEED DANIE MEINTJES AS CEO OF COMPANY.MEDICLINIC INTERNATIONAL - MEINTJES WILL REMAIN AN EXECUTIVE DIRECTOR OF COMPANY UNTIL CONCLUSION OF COMPANY'S ANNUAL GENERAL MEETING TO BE HELD ON 25 JULY 2018.  Full Article

Mediclinic International appoints Carel Aron Van Der Merwe as CEO designate​
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Mediclinic International Plc ::‍ANNOUNCES APPOINTMENT OF CAREL ARON VAN DER MERWE, CURRENTLY GROUP CHIEF CLINICAL OFFICER, AS CHIEF EXECUTIVE OFFICER DESIGNATE​.MERWE ‍TO SUCCEED DANIE MEINTJES AS CEO OF COMPANY ON A DATE TO BE MUTUALLY AGREED, BUT NOT LATER THAN 1 AUGUST 2018​.  Full Article

Mediclinic International says H1 2018 ‍underlying EPS down 12 pct to 11.3 pence​
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - MEDICLINIC INTERNATIONAL PLC ::H1 2018 ‍UNDERLYING EARNINGS PER SHARE DOWN 12% TO 11.3 PENCE​.‍H1 REVENUE UP 10% TO GBP1 405M; FLAT IN CONSTANT CURRENCY TERMS​.‍H1 UNDERLYING EBITDA UP 5% TO GBP232M; DECREASED BY 5% IN CONSTANT CURRENCY TERMS​.‍INTERIM DIVIDEND MAINTAINED AT 3.20 PENCE PER SHARE​.SEES MODEST REVENUE GROWTH IN ‍HIRSLANDEN FOR H2​.‍FOR SOUTHERN AFRICA GROUP EXPECTS REVENUE GROWTH TO BE AROUND 4%​ IN H2.‍SEES MARGINAL IMPROVEMENT IN MIDDLE EAST REVENUES FOR FULL YEAR, GRADUAL IMPROVEMENT IN UNDERLYING EBITDA MARGINS OVER TIME,​.‍HAD A GOOD START TO SECOND HALF OF FINANCIAL YEAR, WITH CURRENT TRADING ACROSS ALL OPERATING DIVISIONS IN LINE WITH EXPECTATIONS​.‍GUIDANCE FOR ALL OPERATING DIVISIONS REMAINS UNCHANGED WITH CURRENT 2H18 TRADING IN LINE WITH MANAGEMENT​.  Full Article

Mediclinic confirms approach to Spire; says considering position
Monday, 23 Oct 2017 

Oct 23 (Reuters) - Mediclinic International Plc ::MEDICLINIC INTNL PLC - STATEMENT RE POSSIBLE OFFER.MEDICLINIC INTERNATIONAL PLC - ‍ANNOUNCEMENT REGARDING SPIRE HEALTHCARE GROUP PLC​.‍MEDICLINIC NOTES ANNOUNCEMENT MADE BY SPIRE HEALTHCARE GROUP PLC ("SPIRE") EARLIER TODAY​.MEDICLINIC - ‍CONFIRMS THAT IT MADE AN APPROACH TO SPIRE REGARDING A POSSIBLE OFFER FOR ENTIRE ISSUED AND TO BE ISSUED SHARE CAPITAL OF SPIRE​.‍PROPOSAL WAS REJECTED BY INDEPENDENT DIRECTORS OF SPIRE. AS A CONSEQUENCE, MEDICLINIC IS CONSIDERING ITS POSITION​.  Full Article

UK's Spire says rejects bid from Mediclinic Intl
Monday, 23 Oct 2017 

Oct 23 (Reuters) - Spire Healthcare Group Plc ::SPIRE HEALTHCARE GRP - RESPONSE TO PRESS SPECULATION.SPIRE HEALTHCARE - ‍RECEIVED PRELIMINARY AND CONDITIONAL PROPOSAL FROM MEDICLINIC INTERNATIONAL PLC.SPIRE HEALTHCARE - ‍RECEIVED PROPOSAL TO ACQUIRE ALL OF ISSUED AND TO BE ISSUED SHARES OF SPIRE WHICH MEDICLINIC DOES NOT ALREADY OWN​.‍PROPOSAL COMPRISED 150 PENCE IN CASH AND 0.232 NEW MEDICLINIC SHARES PER SPIRE SHARE​.‍PROPOSAL VALUED EACH SPIRE SHARE AT 298.6 PENCE PER SHARE​.BOARD ‍UNANIMOUSLY REJECTED OFFER ON BASIS THAT IT SIGNIFICANTLY UNDERVALUES SPIRE AND ITS PROSPECTS​.‍SHAREHOLDERS ARE STRONGLY ADVISED TO TAKE NO ACTION IN RELATION TO PROPOSAL​.‍THERE CAN BE NO CERTAINTY THAT AN OFFER WILL BE MADE OR AS TO TERMS ON WHICH ANY OFFER MIGHT BE MADE​.  Full Article

Mediclinic International says H1 revenue up 9.5 pct at GBP1.4 billion
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Mediclinic International Plc :‍2017/18 INTERIM TRADING UPDATE​.‍1H18 REVENUE WAS UP 9.5% AT GBP1.4BN (1H17: GBP1.3BN) ​.H1 UNDERLYING EBITDA WAS UP 5.0% AT GBP231M (1H17: GBP220M)​.H1 ‍UNDERLYING EARNINGS PER SHARE IS EXPECTED TO BE AROUND 11.5 PENCE (1H17: 12.8 PENCE)​.TEAMS IN SOUTH AFRICA , SWITERLAND IMPLEMENTED COST SAVINGS PROGRAMMES, PRODUCTIVITY INITIATIVES TO HELP MARGINS DURING H2‍​.‍NEW FACILITIES WILL REDUCE COST OF DEBT ON A LIKE FOR LIKE BASIS BY 25BPS AND EXTEND MATURITY PROFILE TO AT LEAST 2023​.  Full Article

Mediclinic implements cost savings programmes in S. Africa, Switzerland
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Mediclinic International Plc ::FY MARGIN EXPECTATIONS FOR SOUTH AFRICAN BUSINESS (NOT FOR COMPANY) REMAIN IN LINE WITH PREVIOUS GUIDANCE, BROADLY STABLE ON PRIOR YEAR, AT AROUND 21%​.TEAMS IN SOUTH AFRICA, SWITZERLAND IMPLEMENTED COST SAVINGS PROGRAMMES, PRODUCTIVITY INITIATIVES TO HELP MARGINS DURING H2.  Full Article

Mediclinic International says CEO has informed board of his intention to retire
Tuesday, 25 Jul 2017 

July 25 (Reuters) - MEDICLINIC INTERNATIONAL PLC ::MEDICLINIC INTERNATIONAL PLC SAYS COMPANY ANNOUNCES THAT ON 24 JULY 2017, DANIE MEINTJES INFORMED BOARD OF HIS INTENTION TO RETIRE FROM HIS POSITION AS CEO.MEDICLINIC INTERNATIONAL PLC - NOMINATION COMMITTEE WILL BEGIN A SEARCH TO IDENTIFY A SUCCESSOR FOR CEO.MEDICLINIC INTERNATIONAL PLC SAYS DANIE MEINTJES INFORMED HIS INTENTION TO RETIRE FROM HIS POSITION AS CEO AND A DIRECTOR OF COMPANY BY 31 JULY 2018.  Full Article

S.Africa's Competition Commission recommends prohibition of Mediclinic, Matlosana deal
Thursday, 6 Jul 2017 

July 6 (Reuters) - South Africa's Competition Commission::Commission has recommended to tribunal that Mediclinic Southern Africa, Matlosana Medical Health Services deal be prohibited.Proposed merger is likely to substantially prevent or lessen competition in market for provision of private healthcare services in Klerksdorp and surrounding areas.Proposed merger also raises public interest concerns as it significantly and negatively affects a particular industrial region around Klerksdorp.  Full Article

Mediclinic International posts FY EPS 31 pence
Wednesday, 24 May 2017 

May 24 (Reuters) - Mediclinic International Plc ::FY revenue up 30% to £2749m; up 15% compared to pro forma FY16 revenue including al noor.FY underlying EBITDA up 17% to £501m.FY earnings 229 million stg versus 177 million stg year ago.FY underlying EBITDA margin decreased to 18.2% from 20.4%.Fy earnings per share 31 pence versus 29.6 pence year ago.FY operating profit up 26% to £362m.Board proposes final dividend of 4.70 pence per ordinary share for year ended 31 march 2017.Says group is well-positioned to deliver long-term value to shareholders with well-balanced portfolio of global operations.  Full Article

Photo

Corporate earnings boost most stocks, oil surges higher

NEW YORK U.S. stocks ended mixed on Wednesday while most other global shares rose, as investors were drawn to riskier assets because of upbeat earnings from companies in Europe and the United States.